Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook.

Sabir F, Ismail R, Csoka I.

Drug Discov Today. 2019 Oct 17. pii: S1359-6446(19)30388-5. doi: 10.1016/j.drudis.2019.10.005. [Epub ahead of print] Review.

PMID:
31629966
2.

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.

Karim R, Palazzo C, Evrard B, Piel G.

J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16. Review.

PMID:
26892752
3.

Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.

Agarwal S, Muniyandi P, Maekawa T, Kumar DS.

Int J Pharm. 2018 Nov 15;551(1-2):339-361. doi: 10.1016/j.ijpharm.2018.09.033. Epub 2018 Sep 17. Review.

PMID:
30236647
4.

Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells.

Hayward SL, Wilson CL, Kidambi S.

Oncotarget. 2016 Jun 7;7(23):34158-71. doi: 10.18632/oncotarget.8926.

5.

Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.

Dréan A, Goldwirt L, Verreault M, Canney M, Schmitt C, Guehennec J, Delattre JY, Carpentier A, Idbaih A.

Expert Rev Neurother. 2016 Nov;16(11):1285-1300. Epub 2016 Jul 4. Review. Erratum in: Expert Rev Neurother. 2016 Nov;16(11):iv.

PMID:
27310463
6.

Targeted Vascular Drug Delivery in Cerebral Cancer.

Humle N, Johnsen KB, Arendt GA, Nielsen RP, Moos T, Thomsen LB.

Curr Pharm Des. 2016;22(35):5487-5504. Review.

PMID:
27464719
7.

Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.

Baumann BC, Kao GD, Mahmud A, Harada T, Swift J, Chapman C, Xu X, Discher DE, Dorsey JF.

Oncotarget. 2013 Jan;4(1):64-79.

8.

Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy.

Wang X, Zhang Q, Lv L, Fu J, Jiang Y, Xin H, Yao Q.

Drug Deliv. 2017 Nov;24(1):1401-1409. doi: 10.1080/10717544.2017.1378940.

PMID:
28933201
9.

Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.

Fan Y, Chen M, Zhang J, Maincent P, Xia X, Wu W.

Crit Rev Ther Drug Carrier Syst. 2018;35(5):433-467. doi: 10.1615/CritRevTherDrugCarrierSyst.2018024697. Review.

PMID:
30317945
10.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
11.

Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.

Zeng A, Ye T, Cao D, Huang X, Yang Y, Chen X, Xie Y, Yao S, Zhao C.

Sci Rep. 2017 Oct 30;7(1):14372. doi: 10.1038/s41598-017-14766-2.

12.

Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.

Liao W, Fan S, Zheng Y, Liao S, Xiong Y, Li Y, Liu J.

Curr Med Chem. 2018 May 13. doi: 10.2174/0929867325666180514113136. [Epub ahead of print]

PMID:
29768997
13.

Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.

Choudhury H, Pandey M, Chin PX, Phang YL, Cheah JY, Ooi SC, Mak KK, Pichika MR, Kesharwani P, Hussain Z, Gorain B.

Drug Deliv Transl Res. 2018 Oct;8(5):1545-1563. doi: 10.1007/s13346-018-0552-2. Review.

PMID:
29916012
14.

New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it.

Peschillo S, Caporlingua A, Diana F, Caporlingua F, Delfini R.

J Neurointerv Surg. 2016 Oct;8(10):1078-82. doi: 10.1136/neurintsurg-2015-012048. Epub 2015 Nov 5. Review.

PMID:
26541791
15.

Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.

Jena L, McErlean E, McCarthy H.

Drug Deliv Transl Res. 2019 Nov 14. doi: 10.1007/s13346-019-00679-2. [Epub ahead of print] Review.

PMID:
31728942
16.

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A.

J Control Release. 2018 Jul 10;281:139-177. doi: 10.1016/j.jconrel.2018.05.011. Epub 2018 May 24. Review.

PMID:
29772289
17.

The potential of polymeric micelles in the context of glioblastoma therapy.

Morshed RA, Cheng Y, Auffinger B, Wegscheid ML, Lesniak MS.

Front Pharmacol. 2013 Dec 30;4:157. doi: 10.3389/fphar.2013.00157. Review.

18.

Harnessing nanomedicine for therapeutic intervention in glioblastoma.

Gutkin A, Cohen ZR, Peer D.

Expert Opin Drug Deliv. 2016 Nov;13(11):1573-1582. Epub 2016 Jun 27. Review.

PMID:
27292970
19.

Recent expansions of novel strategies towards the drug targeting into the brain.

Alexander A, Agrawal M, Uddin A, Siddique S, Shehata AM, Shaker MA, Ata Ur Rahman S, Abdul MIM, Shaker MA.

Int J Nanomedicine. 2019 Jul 30;14:5895-5909. doi: 10.2147/IJN.S210876. eCollection 2019. Review.

20.

Drug delivery approaches for the treatment of glioblastoma multiforme.

Fakhoury M.

Artif Cells Nanomed Biotechnol. 2016 Sep;44(6):1365-73. doi: 10.3109/21691401.2015.1052467. Epub 2015 Jun 5. Review.

PMID:
26046399

Supplemental Content

Support Center